# Nuclide record ga-67-citrate (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/ga-67-citrate/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "ga-67-citrate" ;
  schema:name "Gallium citrate Ga-67"@en ;
  schema:alternateName "67Ga-citrate"@en, "Gallium Citrate Ga 67"@en ;
  schema:description "One of the oldest cancer-imaging scans still on the market: an injectable form of radioactive gallium that collects in lymphomas and some other tumours (and in infections), imaged one to five days later. It has mostly been replaced by FDG-PET but is still FDA-approved and occasionally used."@en ;
  schema:url <https://nuclide.cc/drugs/ga-67-citrate/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5f670c12-cca5-4d73-8a88-241f753d1bc7> ;
  nuclide:status "approved" ;
  nuclide:tag "legacy agent", "lymphoma imaging", "SPECT" ;
  nuclide:modality "SPECT tracer" ;
  nuclide:approval "US 1976: Demonstrating the presence and extent of Hodgkin's disease, lymphoma and bronchogenic carcinoma; aid in detecting some acute inflammatory lesions" ;
  nuclide:related <https://nuclide.cc/isotopes/ga-67/> ;
  nuclide:technologies <https://nuclide.cc/technologies/spect/>, <https://nuclide.cc/technologies/spect-ct/> ;
  nuclide:companies <https://nuclide.cc/companies/curium/> .